Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PKNOX2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | RP11-574K11.31 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | PIP5K1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | CTSZ | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | PPT2-EGFL8 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | PDE2A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | LIPE | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | CLEC17A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | EIF2AK3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | SH3TC2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |